Document Detail

Long term prognosis of patients with pediatric pheochromocytoma.
MedLine Citation:
PMID:  24169644     Owner:  NLM     Status:  Publisher    
A third of patients with paraganglial tumors, pheochromocytoma and paraganglioma, carry germline mutations in one of the susceptibility genes, RET, VHL, NF1, SDHAF2, SDHA, SDHB, SDHC, SDHD, TMEM127 and MAX. Despite increasing importance, data for long-term prognosis are scarce in pediatric presentations. The European-American-Pheochromocytoma-Paraganglioma-Registry, with a total of 2001 patients with confirmed paraganglial tumors, was the platform for this study. Molecular genetic and phenotypic classification and assessment of gene-specific long-term outcome with second and/or malignant paraganglial tumors and life expectancy was performed in patients diagnosed <18 years. Of 177 eligible registrants, 80% had mutations, 49% VHL, 15% SDHB, 10% SDHD, 4% NF1 and one patient each in RET, SDHA and SDHC. A second primary paraganglial tumor developed in 38% with increasing frequency over time, reaching 50% at 30 years after initial diagnosis. Their prevalence was associated with hereditary disease (p=0.001), particularly in VHL and SDHD mutation carriers (VHL vs others, p=0.001, SDHD vs others, p=0.042). A total of 16 (9%) patients with hereditary disease had malignant tumors, 10 at initial diagnosis and another 6 during follow-up. The highest prevalence was associated with SDHB (SDHB vs others, p<0.001). Eight patients died (5%), all of whom had germline mutations. Mean life expectancy was 62 years with hereditary disease. Hereditary disease and the underlying germline mutation define the long-term prognosis of pediatric patients in terms of prevalence and time of second primaries, malignant transformation and survival. Based on these data, gene-adjusted, specific surveillance guidelines can help effective preventive medicine.
Birke Bausch; Ulrich Wellner; Dirk Bausch; Francesca Schiavi; Marta Barontini; Gabriela Sanso; Martin K Walz; Mariola Peczkowska; Georges Weryha; Patrizia Dall'igna; Giovanni Cecchetto; Gianni Bisogno; Lars Moeller; Detlef Bockenhauer; Attila Patocs; Karoly Racz; Dmitry Zabolotnyi; Svetlana Yaremchuk; Iveta Dzivite-Krisane; Frederic Castinetti; David Taieb; Angelica Malinoc; Ernst von Dobschuetz; Jochen Roessler; Kurt Werner Schmid; Giuseppe Opocher; Charis Eng; Hartmut P H Neumann
Related Documents :
24913064 - Severe congenital cutis laxa with cardiovascular manifestations due to homozygous delet...
23725154 - Associations of il-10 gene polymorphisms with acute myeloid leukemia in hunan, china.
10488864 - An orthopaedic scoring system for nail-patella syndrome and application to a kindred wi...
19427854 - Role of mitofusin 2 mutations in the physiopathology of charcot-marie-tooth disease typ...
17637734 - Mutation rate variation in multicellular eukaryotes: causes and consequences.
7504284 - Myelin protein zero gene mutated in charcot-marie-tooth type 1b patients.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-10-29
Journal Detail:
Title:  Endocrine-related cancer     Volume:  -     ISSN:  1479-6821     ISO Abbreviation:  Endocr. Relat. Cancer     Publication Date:  2013 Oct 
Date Detail:
Created Date:  2013-10-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9436481     Medline TA:  Endocr Relat Cancer     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
B Bausch, Innere Medizin 2, Universitätsklinikum Freiburg, Freiburg, 79106, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Orientational relaxation in semiflexible dendrimers.
Next Document:  Sex-linked and autosomal microsatellites provide new insights into island populations of the tammar ...